Executive Summary: State-of-the-Art Review: Hepatitis C

By afschroeder • September 20, 2025

Lo Re V 3rd, Bhattacharya D, Price J, Aronsohn A, Kim HN, Falade-Nwulia S, Zimmerman M, Trooskin S, Torgersen J. Executive Summary: State-of-the-Art Review: Hepatitis C. Clin Infect Dis. 2025 Sep 16;81(2):217-219. doi: 10.1093/cid/ciaf335. PMID: 40971898.

Tags: cascade of care, direct-acting antiviral therapy, HCV elimination, HCV infection, hepatitis C virus, Infectious Diseases, Publications, Veterans Administration

The Use of Genetics and Immunology in the Diagnosis and Care of Advanced Coccidioidomycosis: Where Are We Going?

Thiagarajan K, Mishra S, Purdie R, Torres B, Johnson RH, Butte MJ. The Use of Genetics and Immunology in the Diagnosis and Care of Advanced[...]

Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2

Grinspoon SK, Zhao S, Martinez E, Fichtenbaum CJ, Chu SM, Diggs MR, Umbleja T, McCallum S, Fitch KV, Triant VA, Currier JS, Aberg JA, Malvestutto[...]

Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles

Moucheraud C, Trujillo D, Wagner Z, Garland W, Smith T, Hoffman RM, Landovitz RJ. Preferences for HIV prevention conditional cash transfers among Black/African American and[...]